1. Home
  2. ARWR vs DV Comparison

ARWR vs DV Comparison

Compare ARWR & DV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • DV
  • Stock Information
  • Founded
  • ARWR 2003
  • DV 2008
  • Country
  • ARWR United States
  • DV United States
  • Employees
  • ARWR 525
  • DV N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • DV Computer Software: Prepackaged Software
  • Sector
  • ARWR Health Care
  • DV Technology
  • Exchange
  • ARWR Nasdaq
  • DV Nasdaq
  • Market Cap
  • ARWR 2.7B
  • DV 3.0B
  • IPO Year
  • ARWR 1993
  • DV 2021
  • Fundamental
  • Price
  • ARWR $22.04
  • DV $20.62
  • Analyst Decision
  • ARWR Buy
  • DV Buy
  • Analyst Count
  • ARWR 12
  • DV 19
  • Target Price
  • ARWR $42.70
  • DV $25.67
  • AVG Volume (30 Days)
  • ARWR 2.0M
  • DV 1.3M
  • Earning Date
  • ARWR 02-04-2025
  • DV 11-06-2024
  • Dividend Yield
  • ARWR N/A
  • DV N/A
  • EPS Growth
  • ARWR N/A
  • DV 18.39
  • EPS
  • ARWR N/A
  • DV 0.38
  • Revenue
  • ARWR $3,551,000.00
  • DV $638,459,000.00
  • Revenue This Year
  • ARWR $4,225.26
  • DV $19.30
  • Revenue Next Year
  • ARWR $59.48
  • DV $13.00
  • P/E Ratio
  • ARWR N/A
  • DV $52.91
  • Revenue Growth
  • ARWR N/A
  • DV 19.57
  • 52 Week Low
  • ARWR $17.05
  • DV $16.12
  • 52 Week High
  • ARWR $39.83
  • DV $43.00
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 50.44
  • DV 58.38
  • Support Level
  • ARWR $21.48
  • DV $19.75
  • Resistance Level
  • ARWR $22.47
  • DV $20.83
  • Average True Range (ATR)
  • ARWR 1.27
  • DV 0.51
  • MACD
  • ARWR -0.23
  • DV -0.12
  • Stochastic Oscillator
  • ARWR 12.63
  • DV 55.45

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

About DV DoubleVerify Holdings Inc.

DoubleVerify Holdings Inc is a digital media measurement and analytics software platform. The DV Authentic Ad ensures that a digital ad was delivered in a brand-safe setting, completely viewable, by a real individual, and in the expected geography, is one of its solutions. It generates revenues from its advertisement customers by charging a Measured Transaction Fee on the volume of Media Transactions Measured on the software platform.

Share on Social Networks: